Imaging modality (performed on n patients) | No. of patients with positive lesions | Mean no. of lesions per patient (range) |
---|---|---|
CT or MRI (n = 18) | 7 | 4.7 (0–18) |
DMSA-V (n = 18) | 5 | 1.1 (0–13) |
18F-FDG PET (n = 17) | 4 | 1.6 (0–18) |
18F-DOPA PET (21) | 13 | 4.6 (0–21) |
On the basis of the inclusion criteria, all patients were considered positive for tumor. Sensitivities for patient-based analysis were calculated using total number of patients scanned per imaging modality as reference.